2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
Clinical trial NCT02916056 · TERMINATED
Trial details
- NCT number
- NCT02916056
- Sponsor
- vTv Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-06-01
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.